-The Times of India MUMBAI: Treatment for HIV patients across India has taken a hit, especially in Delhi and Mumbai, due to severe stock-outs of life-saving medicines reported at government-owned centres. Shortage of first-line (initial), second-line (advanced) and paediatric HIV drugs, besides crucial diagnostic kits, has prompted patient groups to send a legal notice to the government, pointing to the scarcity, gaps in procurement and supply of these drugs. The treatment and control...

A recent study published in the prestigious science journal 'PLOS One' (August 2014) shows that Central programmes like National Rural Health Mission (NRHM) and Rashtriya Swasthya Bima Yojana (RSBY), and state-level initiatives like Yeshasvini health insurance scheme (Karnataka), Vajpayee Aarogyasri health insurance scheme (Karnataka), Rajiv Aarogyasri scheme (Andhra Pradesh), Chief Minister's Insurance Scheme for Life Saving Treatment (Tamil Nadu) etc. did little to reduce the financial burden arising out of...

-The Hindustan Times New Delhi: Life-saving drugs that need to be stored at low temperatures left out in the open, touts having a free run of transport offices and schools violating guidelines - all this and more was unearthed during raids by the Delhi government officers on Thursday. On the directions of the Lieutenant Governor Najeeb Jung, 19 teams of senior officers fanned out in the city, exposing thriving malpractices in...

-Down to Earth Giving patents to foreign-made medicines will add to patients' woes, they urge Health activists staged a protest in front of the office of Union Ministry of Health and Family Welfare on Friday, demanding that the government should ensure that oral drugs to treat Hepatitis C are made available to patients. The demonstrators were later assured by the ministry officials that they would look into the matter...

-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...